Point-of-care Molecular Diagnostics Market
Point-of-care Molecular Diagnostics Market by Product & Service, Technology, Application & Region - Forecast 2022 - 2032
Market Insights on Point-of-care Molecular Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Point-of-Care Molecular Diagnostics Market Outlook (2022-2032)
[321 Pages Report] The global point-of-care molecular diagnostics market size was estimated to be worth US$ 3 Bn in 2021 and is forecast to grow at a robust CAGR of 8% during the assessment period from 2022 and 2032, reaching around US$ 11 Bn by 2032. Rising prevalence of infectious diseases and cancer worldwide and growing end user preference for point of care molecular testing due to its attractive features are the major forces behind the expansion of point-of-care molecular diagnostics market.
Market Outlook:
|
Data Points |
Market Insights |
|
Point-of-Care Molecular Diagnostics Market Value 2021 |
USD 3 Bn |
|
Point-of-Care Molecular Diagnostics Market Value 2032 |
USD 11 Bn |
|
Point-of-Care Molecular Diagnostics Market Forecast CAGR 2022-2032 |
8% |
|
Point-of-care Molecular Diagnostics Market Attraction |
Breakthroughs in proteomics and molecular methods to bring improvements |
|
Key Players |
Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.) |
Molecular diagnostics has been used by medical professionals in laboratories and other healthcare settings for a long time. However, various drawbacks such as high cost of tests, time consuming nature and delay in results of molecular diagnostics has prompted them to look for better diagnostic solutions. This has brought point-of-care molecular diagnostic market into the spotlight.
Point-of-care molecular diagnostics has gained a lot of traction across end use verticals including hospitals and research institutions due to its ability to reduce turnaround time and provide rapid and accurate results. Point of care molecular testing allows the rapid and early detection of diseases in non-laboratory settings. These tests are usually performed at nearby patients' locations.
Rising adoption of point of care molecular diagnostic solutions for the early detection of a wide range of diseases ranging from respiratory diseases and cancer to sexually transmitted diseases and gastrointestinal disorders is a key factor driving the growth in point-of-care molecular diagnostics market.
Similarly, rapid growth in molecular diagnostics market and molecular imaging market supported by growing health awareness among people across emerging economies will create opportunities for point of care molecular diagnostics manufacturers during the forthcoming years.
Furthermore, recent advancements in microfluidics and genetic sequencing coupled with development of low-cost and rapid point-of-care molecular diagnostic platforms will boost sales of POC molecular diagnostics products, thereby expanding the molecular POC tests market size.
Let us know your requirement to get
100% FREE customization
Point-of-Care Molecular Diagnostics Demand Analysis (2015-2021) Compared to Market Forecasts (2022-2032)
The global demand for point-of-care molecular diagnostics is anticipated to grow at a healthy CAGR of around 8% during the forecast period between 2022 and 2032. Rising prevalence of chronic and infectious diseases, increased focus on decentralized diagnostics, bourgeoning spending in research and development activities worldwide, growing need for early detection of infectious diseases, and faster development and commercialization of advanced technologies are some of the major factors expected to drive growth in the global point-of-care molecular diagnostics market.
Besides this, improved therapeutic and diagnostic alternatives, such as personalized medicine and biomarker identification along with breakthroughs in proteomics and molecular methods and surge in adoption of point of care molecular PCR is expected to further boost the sales of POC molecular diagnostic products during the forecast period.
Point of care molecular diagnostic testing has become a highly sought-after method for analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. It allows physicians to improve the standard of care by combining the ability to quickly make a diagnosis and treatment decision during the patient’s initial visit rather than having to wait for hours.
Increasing incidence of infectious disease and cancer is providing a major impetus to the growth of point of care molecular diagnostics market and the trend is likely to escalate during the forecast period. According to the American Cancer Society, an estimated 1.9 million new cancer cases and 609,360 deaths from cancer are expected to occur in the US during 2022.
Similarly, increasing public-private funding in research and development coupled with advancement in personalized medicine and growing popularity of POC molecular diagnostics in preventive healthcare will generate sales prospects for POC molecular diagnostic products in the future.
Which Factors are Restraining the Growth of Point-of-Care Molecular Diagnostics Market?
Despite a positive outlook, the global point-of-care molecular diagnostics market is facing various challenges that are likely to restrict its growth during the forecast period. Some of these factors are the absence of proper reimbursement policies, lack of awareness across developing regions, and poor penetration of advanced point-of-care molecular diagnostic devices in some regions.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-Wise Insights
How Will Growth Unfold in the U.S Point of Care Molecular Diagnostics Market?
According to the Future Market Insights, the U.S. point-of-care molecular diagnostics market is forecast to grow at a healthy CAGR over the forecast period, owing to the increased research operations for the development of novel products, presence of leading market players, rise in cases of cancer and several infectious diseases, favorable government support, and rapid expansion of automated molecular diagnostics testing system market.
The North American point-of-care molecular diagnostics market which was worth more than US$ 1.4 billion in 2020 was mostly dominated by the U.S. and the trend shows that this will continue to prevail during the forecast period as well.
Most of the end users across the United States are showing a keen inclination towards employing POC tests for safe and early diagnosis of infectious diseases. Similarly, increasing spending in research and development for introducing advanced POC molecular diagnostic tests will create sales prospects for point-of-care molecular diagnostic platforms in future.
Furthermore, increasing usage of point of care molecular PCR, commercialization of real-time PCR products, and growing popularity of point of care molecular covid test will assist market growth in the region.
Why is Demand for Point-of-Care Molecular Diagnostics Rising Across the U.K.?
The U.K point-of-care molecular diagnostics market is poised to exhibit strong growth during the forecast period owing to the presence of a highly established healthcare industry, rapid growth of molecular diagnostics market, increasing investments by government and non-government organizations in research and development, and growing adoption of point of care molecular PCR across end use verticals.
Similarly, rise in cases of infectious diseases, gastrointestinal disorders, and cancers is spurring the POC molecular diagnostics sales in the region. According to Cancer Research UK, there were around 375400 new cases of cancer in the U.K between 2016 and 2018.
Category-Wise Insights
Which Product & Service Segment Leads the Point-of-Care Molecular Diagnostics Market?
“Assays & Kits to Remain High in Demand Across End Use Verticals”
By product & service, assays & kits segment dominated the global point-of-care molecular diagnostics market in 2021 and is projected to grow at a robust pace during the assessment period. Rising adoption of these products across major end use verticals is triggering the growth of this segment.
Similarly, growing popularity of point of care molecular testing due to its highly accurate and quicker nature will continue to fuel the demand for assays & kits during the forecast period.
Which is the Most Lucrative Application for Point-of-Care Molecular Diagnostics?
“Surge in Respiratory Diseases to Boost Sales of POC Molecular Diagnostic Products”
Based on application, the respiratory diseases segment is expected to remain the most lucrative application area for point-of-care molecular diagnostics. This is attributable to the rising prevalence of respiratory diseases worldwide and advancements in infectious illness POC molecular testing.
For instance, according to a report published in The LANCET, there were around 17.2 billion cases of upper respiratory infections (URIs) globally in 2019. This will continue to expand the POC tests market size and help molecular diagnostics manufacturers to increase their sales.
Which Technology Segment Contributed the Most in Point-of-Care Molecular Diagnostics Market?
“RT-PCR to Remain the Most Preferred Technology in the Global Point-of-Care Molecular Diagnostics Market”
As per FMI, RT-PCR segment accounted for the largest revenue share in the global point-of-care molecular diagnostics market in 2021 and is forecast to further grow at a healthy pace. Increasing usage of RT-PCR in proteomics, genomics, and COVID-19 testing, availability of portable and easy-to-use instruments, and growing end user preference for RT-PCR due to its various benefits including high sensitivity and specificity, cost effectiveness, and less time-consuming nature are some of the factors triggering the segment growth.
Furthermore, expansion of RT-PCR kits market across the world is likely to favor the growth of this segment during the upcoming years.
Which End User Segment Leads the Point-of-Care Molecular Diagnostics Market?
“Hospitals & ICUs Remain Ideal Destinations for Point-of-Care Molecular Testing”
Based on end users, hospitals & ICUs segment accounts for the largest revenue share of the point-of-care molecular diagnostics market. Rise in the number of hospitals coupled with increasing adoption of point of care molecular testing in hospitals and ICUs for fast and accurate detection of diseases is favoring growth of this segment.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Key POC molecular diagnostic manufacturers operating in the market include Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.). These players are constantly focusing on developing innovative point-of-care molecular diagnostic platforms such as point-of-care molecular COVID test and paper-based nucleic acid amplification tests, and that can effectively detect diseases with ease. Furthermore, they have adopted strategies like mergers, acquisitions, partnerships etc. to expand their global footprint.
- In March 2020, Abbott Laboratories ID NOW point-of-care test for the detection of coronavirus.
- In July 2021, QuantuMDx launched Q-POC™, a rapid, PCR point of care diagnostic system.
- In 2022, Co-Diagnostics, a molecular diagnostics company completed the acquisition of Idaho Molecular and Advanced Conceptions.
Point-of-Care Molecular Diagnostics Market Report Scope
With the aim of providing a complete and detailed industry analysis, FMI’s latest report on the point-of-care molecular diagnostics market digs deep into key drivers, prevailing trends and emerging opportunities affecting the market dynamics. It uncovers key investment pockets within the point-of-care molecular diagnostics market and explains how prominent molecular diagnostics manufactures are innovating to meet end user demands.
Through a systemic approach, the report provides solutions to queries like how advancement in molecular diagnostic technology is influencing the POC molecular diagnostics sales? Why is North America becoming an attractive destination for point-of-care molecular diagnostic devices? And how will expansion of molecular diagnostics market create growth prospects for the manufacturers of point-of-care molecular diagnostics platforms?
FMI also attempts to provide insights into factors pushing sales of point-of-care molecular diagnostics products across developed and developing regions. The report further dedicates certain chapters to analyzing leading segments along with their market shares.
Want to get a comprehensive assessment of point-of-care molecular diagnostic market and understand the futuristic growth projections? Keep in touch with one of the leading research companies of the world “Future Market Insights”.
The Point-of-Care Molecular Diagnostics market analysis includes:
- A 10-year realistic point-of-care molecular diagnostics sales forecast across multiple verticals
- Comprehensive information on demand forecasting and sales prospects across 25 countries
- Impact of novel infectious diseases including COVID-19 on the sales of POC molecular diagnostics products
- Detailed analysis of regional pockets along with degree of market penetration
- Information about emerging end user demands
- Key insights into leading market and product segments along with their respective shares, growth forecast and market potential
- Top POC molecular diagnostic manufacturers in the market, and key competitive factors
- An in-depth analysis of growth strategies adopted by top players to penetrate attractive markets
- Knowledge about the key challenges and winning imperatives in this Market
- Market dynamics including drivers, restraints and emerging trends
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historic Data Available for |
2015-2021 |
|
Market Analysis |
USD Million for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
|
|
Key regions covered |
North America
Latin America
Western Europe
Eastern Europe
South Asia Pacific
Middle East & Africa
Rest of the World
|
|
End User |
|
|
Key companies profiled |
Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux S.A. (France), Danaher Corporation (U.S.), Quidel Corporation (U.S.), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. Biocartis NV (Belgium), Meridian Bioscience, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.) |
|
Customization & pricing |
Available upon request |
Point-of-Care Molecular Diagnostics Market Key Segments
By Product & Service:
- Assays & kits
- Instruments & Analyzers
- Software & Services
By Technology:
- RT-PCR
- INAAT
- Other technologies
By Application:
- Respiratory Diseases
- Sexually Transmitted Diseases
- Hospital-acquired Infections
- Cancer
- Hepatitis
- Gastrointestinal Disorders
- Other Applications
By End User:
- Physicians’ Offices
- Hospitals & ICUs
- Research Institutes
- Other End Users
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The global point-of-care molecular diagnostics market size was estimated to be worth around US$ 3 Bn in 2021.
As per FMI, point-of-care molecular diagnostics market is expected to grow at 8% CAGR during the forecast period, reaching around US$ 11 Bn by 2032.
North American remains the most dominating market for point-of-care molecular diagnostics.
The assays and kits segment accounts for the largest share of the point-of-care molecular diagnostics market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Point of Care Molecular Diagnostics
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Point of Care Molecular Diagnostics Market, by Key Countries
4.2. Point of Care Molecular Diagnostics Market Opportunity Assessment (US$ Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Point of Care Molecular Diagnostics Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Point of Care Molecular Diagnostics Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Point of Care Molecular Diagnostics Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Point of Care Molecular Diagnostics Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Product & Service
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product & Service, 2015-2021
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product & Service, 2022-2032
8.3.1. Assays & kits
8.3.2. Instruments & Analyzers
8.3.3. Software & Services
8.4. Market Attractiveness Analysis By Product & Service
9. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Technology, 2015-2021
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technology, 2022-2032
9.3.1. RT-PCR
9.3.2. INAAT
9.3.3. Other technologies
9.4. Market Attractiveness Analysis By Technology
10. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Application, 2015-2021
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022-2032
10.3.1. Respiratory Diseases
10.3.2. Sexually Transmitted Diseases
10.3.3. Hospital-acquired Infections
10.3.4. Cancer
10.3.5. Hepatitis
10.3.6. Gastrointestinal Disorders
10.3.7. Other Applications
10.4. Market Attractiveness Analysis By Application
11. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By End User, 2015-2021
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2022-2032
11.3.1. Physicians’ Offices
11.3.2. Hospitals & ICUs
11.3.3. Research Institutes
11.3.4. Other End Users
11.4. Market Attractiveness Analysis By End User
12. Global Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product & Service
13.4.3. By Technology
13.4.4. By End User
13.4.5. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product & Service
13.5.3. By Technology
13.5.4. By End User
13.5.5. By Application
14. Latin America Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product & Service
14.4.3. By Technology
14.4.4. By End User
14.4.5. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product & Service
14.5.3. By Technology
14.5.4. By End User
14.5.5. By Application
15. Europe Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product & Service
15.4.3. By Technology
15.4.4. By End User
15.4.5. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product & Service
15.5.3. By Technology
15.5.4. By End User
15.5.5. By Application
16. Asia Pacific Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product & Service
16.4.3. By Technology
16.4.4. By End User
16.4.5. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product & Service
16.5.3. By Technology
16.5.4. By End User
16.5.5. By Application
17. Middle East and Africa Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product & Service
17.4.3. By Technology
17.4.4. By End User
17.4.5. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product & Service
17.5.3. By Technology
17.5.4. By End User
17.5.5. By Application
18. Key Countries Point of Care Molecular Diagnostics Market Analysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Point of Care Molecular Diagnostics Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Product & Service
18.2.2.2. By Technology
18.2.2.3. By End User
18.2.2.4. By Application
18.3. Canada Point of Care Molecular Diagnostics Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Product & Service
18.3.2.2. By Technology
18.3.2.3. By End User
18.3.2.4. By Application
18.4. Mexico Point of Care Molecular Diagnostics Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Product & Service
18.4.2.2. By Technology
18.4.2.3. By End User
18.4.2.4. By Application
18.5. Brazil Point of Care Molecular Diagnostics Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Product & Service
18.5.2.2. By Technology
18.5.2.3. By End User
18.5.2.4. By Application
18.6. Germany Point of Care Molecular Diagnostics Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Product & Service
18.6.2.2. By Technology
18.6.2.3. By End User
18.6.2.4. By Application
18.7. France Point of Care Molecular Diagnostics Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Product & Service
18.7.2.2. By Technology
18.7.2.3. By End User
18.7.2.4. By Application
18.8. Italy Point of Care Molecular Diagnostics Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Product & Service
18.8.2.2. By Technology
18.8.2.3. By End User
18.8.2.4. By Application
18.9. BENELUX Point of Care Molecular Diagnostics Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Product & Service
18.9.2.2. By Technology
18.9.2.3. By End User
18.9.2.4. By Application
18.10. UK Point of Care Molecular Diagnostics Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Product & Service
18.10.2.2. By Technology
18.10.2.3. By End User
18.10.2.4. By Application
18.11. Nordic Countries Point of Care Molecular Diagnostics Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Product & Service
18.11.2.2. By Technology
18.11.2.3. By End User
18.11.2.4. By Application
18.12. China Point of Care Molecular Diagnostics Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Product & Service
18.12.2.2. By Technology
18.12.2.3. By End User
18.12.2.4. By Application
18.13. Japan Point of Care Molecular Diagnostics Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Product & Service
18.13.2.2. By Technology
18.13.2.3. By End User
18.13.2.4. By Application
18.14. South Korea Point of Care Molecular Diagnostics Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Product & Service
18.14.2.2. By Technology
18.14.2.3. By End User
18.14.2.4. By Application
18.15. GCC Countries Point of Care Molecular Diagnostics Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Product & Service
18.15.2.2. By Technology
18.15.2.3. By End User
18.15.2.4. By Application
18.16. South Africa Point of Care Molecular Diagnostics Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Product & Service
18.16.2.2. By Technology
18.16.2.3. By End User
18.16.2.4. By Application
18.17. Turkey Point of Care Molecular Diagnostics Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Product & Service
18.17.2.2. By Technology
18.17.2.3. By End User
18.17.2.4. By Application
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Abbott Laboratories (US)
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. F.Hoffmann-La Roche Ltd. (Switzerland)
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. bioMérieux SA (France)
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Danaher Corporation (US)
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Quidel Corporation (US)
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. QIAGEN N.V. (Netherlands)
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Co-Diagnostics, Inc. (US)
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Biocartis NV (Belgium)
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Meridian Bioscience, Inc. (US)
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Thermo Fisher Scientific, Inc. (US)
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 2: Global Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 3: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 4: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 5: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 6: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 7: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 8: Global Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 9: Global Point of Care Molecular Diagnostics Market, By Region, 2015 – 2021
Table 10: Global Point of Care Molecular Diagnostics Market, By Region, 2022 – 2032
Table 11: North America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 12: North America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 13: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 14: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 15: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 16: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 17: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 18: North America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 19: North America Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021
Table 20: North America Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032
Table 21: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 22: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 23: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 24: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 25: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 26: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 27: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 28: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 29: Latin America Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021
Table 30: Latin America Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032
Table 31: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 32: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 33: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 34: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 35: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 36: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 37: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 38: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 39: Europe Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021
Table 40: Europe Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032
Table 41: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 42: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 43: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 44: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 45: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 46: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 47: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 48: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 49: Asia Pacific Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021
Table 50: Asia Pacific Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032
Table 51: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2015 – 2021
Table 52: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn),By Product & Service, 2022 – 2032
Table 53: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2015 – 2021
Table 54: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Technology, 2022 – 2032
Table 55: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2015 – 2021
Table 56: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By Application, 2022 – 2032
Table 57: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2015 – 2021
Table 58: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn), By End User, 2022 – 2032
Table 59: MEA Point of Care Molecular Diagnostics Market, By Country, 2015 – 2021
Table 60: MEA Point of Care Molecular Diagnostics Market, By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Point of Care Molecular Diagnostics Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 4: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 5: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 6: Global Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 7: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 8: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 9: Global Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 10: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 11: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 12: Global Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 13: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 14: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 15: Global Point of Care Molecular Diagnostics Market Share, By Region, 2022 & 2032
Figure 16: Global Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 17: Global Point of Care Molecular Diagnostics Market Attractiveness Index, By Region – 2022-2032
Figure 18: North America Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 19: North America Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 20: North America Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 21: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 22: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 23: North America Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 24: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 25: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 26: North America Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 27: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 28: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 29: North America Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 30: North America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 31: North America Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 32: North America Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 34: North America Market Attractiveness Index, By Country – 2022-2032
Figure 35: Latin America Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 36: Latin America Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 37: Latin America Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 38: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 39: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 40: Latin America Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 41: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 42: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 43: Latin America Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 44: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 45: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 46: Latin America Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 47: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 48: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 49: Latin America Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032
Figure 50: Latin America Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 51: Latin America Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 52: Europe Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 53: Europe Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 54: Europe Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 55: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 56: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 57: Europe Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 58: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 59: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 60: Europe Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 61: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 62: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 63: Europe Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 64: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 65: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 66: Europe Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032
Figure 67: Europe Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 68: Europe Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 69: MEA Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 70: MEA Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 71: MEA Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 72: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 73: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 74: MEA Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 75: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 76: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 77: MEA Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 78: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 79: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 80: MEA Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 81: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 82: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 83: MEA Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032
Figure 84: MEA Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 85: MEA Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032
Figure 86: Asia Pacific Point of Care Molecular Diagnostics Market Value (US$ Bn) and Year-on-Year Growth, 2015-2032
Figure 87: Asia Pacific Point of Care Molecular Diagnostics Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 88: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Product & Service, 2022 & 2032
Figure 89: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Product & Service – 2022-2032
Figure 90: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Product & Service – 2022-2032
Figure 91: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Technology, 2022 & 2032
Figure 92: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Technology – 2022-2032
Figure 93: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Technology – 2022-2032
Figure 94: Asia Pacific Point of Care Molecular Diagnostics Market Share, By End User, 2022 & 2032
Figure 95: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By End User – 2022-2032
Figure 96: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By End User – 2022-2032
Figure 97: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Application, 2022 & 2032
Figure 98: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Application – 2022-2032
Figure 99: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Application – 2022-2032
Figure 100: Asia Pacific Point of Care Molecular Diagnostics Market Share, By Country, 2022 & 2032
Figure 101: Asia Pacific Point of Care Molecular Diagnostics Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 102: Asia Pacific Point of Care Molecular Diagnostics Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
